Please enable JavaScript.
Coggle requires JavaScript to display documents.
Week 10: Developmental Disorders & Fetal Congenital Abnormalities…
-
TGA
Prenatal counselling
Prospective parents option for maternal serum screening and nuchal translucency assessment to evaluate risk of chromosomal abnormalities, irrespective of maternal age
-
Availability of carrier status screening for genetic conditions of perceived high prevalence or consequence
A detailed clinical assessment of any particular risk factors for fetal abnormalities or familial genetic conditions
-
Cat A
E.g. Thyroxine, folic acid, metoclopramide, ampicillin
Cat B1
E.g. azithromycin, cefotaxime, gabapentin
-
Cat B3
E.g. mirtazepine, naltrexone
Cat C
E.g. naproxen, nifedipine, oxprenolol, metformin
Cat D
E.g. phenytoin, ramipril, azathioprine
Cat X
E.g. methotrexate, retinoic acid, thalidomide.